Bassiouny AR, Zaky A, Fawky F, Kandeel KM

Idioma: Ingles.
Referencias bibliográficas: 44
Paginas: 516-530
Archivo PDF: 312.32 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 2003; 38: 38-53.

2. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-18.

3. Nadler EP, Li X, Onyedika E, Greco MA. Differential expression of hepatic fibrosis mediators in sick and spontaneously recovered mice with experimental biliary atresia. J Surg Res 2010; 159: 611-7.

4. Galli A, Crabb D, Price D, et al. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology 2000; 31: 101-8.

5. Marra F, Efsen E, Romanelli RG, et al. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000; 119: 466-78.

6. Miyahara T, Schrum L, Rippe R, et al. Peroxisome proliferator- activated receptors and hepatic stellate cell activation. J Biol Chem 2000; 275: 35715-22.

7. Hazra S, Xiong S, Wang J, et al. Peroxisome proliferatoractivated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem 2004; 279: 11392–401.

8. Xu J, Fu Y, Chen A. Activation of peroxisome proliferator- activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 2003; 285: 20-30.

9. Giorgio M, Trinei M, Migliaccio E, Pelicci PG. Hydrogen peroxide: A metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 2007; 8: 722-8.

10. Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal 1999; 11: 1-14.

11. Kawase M, Fujimura M, Morita-Fujimura Y, Chan PH. Reduction of apurinic/apyrimidinic endonuclease expression after transient global cerebral ischemia in rats: Implication of the failure of DNA repair in neuronal apoptosis. Stroke 1999; 30: 441-8.

12. Edwards M, Rassin DK, Izumi T, Mitra S, Perez-Polo JR. APE/Ref-1 responses to oxidative stress in aged rats. J Neurosci Res 1998; 54: 635-8.

13. Seemann S, Hainaut P. Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity. Oncogene 2005; 24: 3853-63.

14. Zaky A, Busso C, Izumi T, Chattopadhyay R, Bassiouny A, Mitra S. Regulation of the human AP-endonuclease (APE1/ Ref-1) expression by the tumor suppressor p53 in response to DNA damage. Nucleic Acids Res 2008; 36: 1555-66.

15. Fu Y, Zheng S, Lin J, et al. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol 2008; 73: 399-409.

16. O’Connell MA, Rushworth SA. Curcumin: potential for hepatic fibrosis therapy? Br J Pharmacol 2008; 153: 403-5.

17. Zheng S, Chen A. Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochem J 2004; 384: 149-57.

18. Zheng S, Chen A. Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol 2006; 290: 883-93.

19. Zhou Y, Zheng S, Lin J, et al. The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro. Lab Invest 2007; 87: 488-98.

20. Zheng S, Chen A. Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol 2006; 290: 883-93.

21. Cheng Y, Ping J, Xu LM. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells. Chin Med J 2007; 120: 794-801.

22. Griffith JQ, Farris EJ. The rat in laboratory investigations. London Lippincott; 1942, p. 460.

23. Wang BE, Wang HJ, Zhu JX, Iiu EY. Experimental and clinical study of the therapeutic effect of composite salviae multiorrhizae on liver fibrosis. Ganzangbing Zazhi 1993; 1: 69-72.

24. Ohkawa H, Ohishi N, Yagi K. Assay of peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.

25. Ellman G. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-7.

26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.

27. Schreiber E, Matthias P, Müller M, and Schaffner W. Rapid detection of octamer binding proteins with ‘mini-extracts’, prepared from a small number of cells. Nuc Acid Res 1989; 17: 6419.

28. Burnette N. Western blotting: electrophretic transfer of proteins from sodium dodecyl sulfate polyacrylamide gel to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Ana Biochem 1981; 112: 195-203.

29. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine- treated rats. Hepatology 2000; 32: 247-55.

30. Zheng S, Chen A. Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochem J 2004; 384: 149-57.

31. Pérez Tamayo R. Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis? Hepatology 1983; 3: 112-20.

32. Basu S. Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients. Toxicology 2003; 189: 113–27.

33. WU J, Norton PA. Animal models of liver fibrosis. Scand J Gastroenterol 1996; 31: 1137-43.

34. Tell G, Damante G, Caldwell D, Kelley MR. The intracellular localization of APE1/Ref-1: More than a passive phenomenon? Antioxid Redox Signal 2005; 7: 367-84.

35. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001; 35: 297-306.

36. Zheng S, Yumei F, Chen A. De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation. Free Radic Biol Med 2007; 43: 444-53.

37. Natsume M, Tsuji H, Harada A, Akiyama M, Yano T, Ishikura H, Nakanishi I, et al. Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice. J Leukoc Biol 1999; 66: 601–60.

38. Bachem MG, Riess U, Gressner AM. Liver fat storing cell proliferation is stimulated by epidermal growth factor/ transforming growth factor alpha and inhibited by transforming growth factor beta. Biochem Biophys Res Commun 1989; 162: 708-14.

39. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989; 84: 1786-93.

40. Friedman SL. Cytokines and fibrogenesis. Semin Liver Dis 1999; 19: 129-40.

41. Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P. Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats. Role of TGF-b modulation and oxidative stress. Fundam Clin Invest 2008; 22: 417-27.

42. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, Bonacchi A, et al. Ligands of peroxisome proliferatoractivated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000; 119: 466-78.

43. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF Jr, Motomura K, Anania FA, et al. Peroxisome proliferator-activated receptorsand hepatic stellate cell activation. J Biol Chem 2000; 275: 35715-22.

44. Safadi R. From kitchen to gut: curcumin in cholestasis. Gut 2010; 59: 565-6.